Thu, Apr 17, 2014, 1:11 PM EDT - U.S. Markets close in 2 hrs 49 mins

Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • scacc1b scacc1b Mar 12, 2013 11:17 AM Flag

    Where else but the Street can those who harm scientific and public health benefit?

    We really must pass laws limiting the amount companies or people can short. Bashers claim it is beneficial to the market, but we have seen flash crashes and general hold downs that lack any sense. Contact your representatives to get laws passed to limit shorting and uncontrolled greed on wall street. If ARNA sold coffee, ARNA's shares would be about $50 by now.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Let's face it. ARNA has gone where few did in 2012. Drug approvals were up for the FDA but still only 39 approvals. That means trolls like Adam Feurstein can bash most small biotechs with the knowledge that he is far more apt to be right. With ARNA, he was dead wrong. So, does he admit it? Of course not. He just changed the focus of his bashing. After many weeks of constantly republishing the tired old "Today's Drug Laggard" hit piece, The Street just repackaged their same garbage.

      • 1 Reply to nohype88
      • AF's stats used: a whopping 56 responders to his post. For someone supposedly trained in statistics, he should know that he can't say anything other than "the majority of the 56 responders (half of which shorters who I work with, one forth are sycophants and 80% of the rest work for hedge funds) believe...." It was not enough to gauge public sentiment. Maybe he should just get on the phone and start calling investors. But like you said, he can't bash something without news to twist, so why not create your own twisted news?

        Sentiment: Strong Buy

 
ARNA
6.215-0.085(-1.35%)1:11 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.